Remicade er blevet sammenlignet med placebo i forbindelse med behandling af ulcerativ colitis (728 patienter), ankyloserende spondylit (70 patienter), arthritis psoriatica (104 patienter) og psoriasis (378 patienter).
For ulcerative colitis (728 patients), ankylosing spondylitis (70 patients), psoriatic arthritis (104 patients) and psoriasis (378 patients), Remicade has been compared with placebo.